The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
ELFABRIO Chiesi Australia Pty Ltd
Product name
ELFABRIO
Sponsor
Accepted date
May-2024
Active ingredients
pegunigalsidase alfa
Proposed indication
Long-term enzyme replacement therapy.
Application type
A (new medicine)
Publication date
May-2024